Skip to content

Public FDA record

Z-0815-2007: GE Healthcare-Americas Signa 3.0T EXCITE Whole Body Magnetic Resonance System

Recall record Z-0815-2007 for GE Medical Systems LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0815-2007
Company in FDA record
GE Medical Systems LLC
FDA classification date
May 18, 2007
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

To provide the 3.0T MRI systems users with the 8-channel brain coil the proper coil weighting software. The proper coil weighting factors for the eight-channel brain coil were not included in the software.

Source facts

Action
The corrective action is already completed and all customers have been notified via a personal visit to each site, to install a software patch beginning June, 2006.
Initiated
2006-06-01
Root cause
Other
Terminated
2008-02-24
Distribution
Worldwide, including USA, China, Finland, Germany, Israel, Italy, Korea, Spain, and Taiwan.
Recall number
Z-0815-2007
Recall status
Terminated
CDRH record ID
51228
FDA classified
2007-05-18
Recall event number
37653

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗